Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Transfusion Reaction 1 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hemorrhage 1 Anemia, Sickle Cell 1

Interventions

Surveys and Questionnaires 9 Cystectomy 6 Blood Specimen Collection 5 Neoadjuvant Therapy 4 Cystoscopy 4 Drug Therapy 3 avelumab 2 Urination 2 Urinary Diversion 2 Surgical Procedures, Operative 2 Radiotherapy 2 Pioglitazone 2 Microarray Analysis 2 Methods 2 Magnetic Resonance Spectroscopy 2 Interviews as Topic 2 Immunohistochemistry 2 Defecation 2 Biopsy 2 5-aminolevulinic acid hexyl ester 2 trastuzumab deruxtecan 1 sargramostim 1 pembrolizumab 1 erdafitinib 1 enfortumab vedotin 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Watchful Waiting 1 Urinary Sediment Analysis 1 Therapeutics 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Urinary Bladder Neoplasms × Blood Transfusion × Clear all

NCT04537221 2020-11-25

NorCys-Transf

Turku University Hospital

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡